Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Mol Pain ; 20: 17448069241258110, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38744422

RESUMO

Recent studies using different experimental approaches demonstrate that silent synapses may exist in the adult cortex including the sensory cortex and anterior cingulate cortex (ACC). The postsynaptic form of long-term potentiation (LTP) in the ACC recruits some of these silent synapses and the activity of calcium-stimulated adenylyl cyclases (ACs) is required for such recruitment. It is unknown if the chemical activation of ACs may recruit silent synapses. In this study, we found that activation of ACs contributed to synaptic potentiation in the ACC of adult mice. Forskolin, a selective activator of ACs, recruited silent responses in the ACC of adult mice. The recruitment was long-lasting. Interestingly, the effect of forskolin was not universal, some silent synapses did not undergo potentiation or recruitment. These findings suggest that these adult cortical synapses are not homogenous. The application of a selective calcium-permeable AMPA receptor inhibitor 1-naphthyl acetyl spermine (NASPM) reversed the potentiation and the recruitment of silent responses, indicating that the AMPA receptor is required. Our results strongly suggest that the AC-dependent postsynaptic AMPA receptor contributes to the recruitment of silent responses at cortical LTP.


Assuntos
Adenilil Ciclases , Colforsina , Giro do Cíngulo , Potenciação de Longa Duração , Animais , Camundongos , Giro do Cíngulo/efeitos dos fármacos , Giro do Cíngulo/metabolismo , Colforsina/farmacologia , Potenciação de Longa Duração/efeitos dos fármacos , Adenilil Ciclases/metabolismo , Masculino , Receptores de AMPA/metabolismo , Camundongos Endogâmicos C57BL , Sinapses/efeitos dos fármacos , Sinapses/metabolismo , Cálcio/metabolismo
2.
Front Cell Neurosci ; 17: 1151489, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37484822

RESUMO

Introduction: Patients undergoing cranial ionizing radiation therapy for brain malignancies are at increased risk of long-term neurocognitive decline, which is poorly understood and currently untreatable. Although the molecular pathogenesis has been intensively researched in many organisms, whether and how ionizing radiation alters functional neurotransmission remains unknown. This is the first study addressing physiological changes in neurotransmission after ionizing radiation exposure. Methods: To elucidate the cellular mechanisms of radiation damage, using calcium imaging, we analyzed the effects of ionizing radiation on the neurotransmitter-evoked responses of prothoracicotropic hormone (PTTH)-releasing neurons in Drosophila larvae, which play essential roles in normal larval development. Results: The neurotransmitters dopamine and tyramine decreased intracellular calcium levels of PTTH neurons in a dose-dependent manner. In gamma irradiated third-instar larvae, a dose of 25 Gy increased the sensitivity of PTTH neurons to dopamine and tyramine, and delayed development, possibly in response to abnormal functional neurotransmission. This irradiation level did not affect the viability and arborization of PTTH neurons and successful survival to adulthood. Exposure to a 40-Gy dose of gamma irradiation decreased the neurotransmitter sensitivity, physiological viability and axo-dendritic length of PTTH neurons. These serious damages led to substantial developmental delays and a precipitous reduction in the percentage of larvae that survived to adulthood. Our results demonstrate that gamma irradiation alters neurotransmitter-evoked responses, indicating synapses are vulnerable targets of ionizing radiation. Discussion: The current study provides new insights into ionizing radiation-induced disruption of physiological neurotransmitter signaling, which should be considered in preventive therapeutic interventions to reduce risks of neurological deficits after photon therapy.

3.
Pharm Biol ; 54(2): 251-9, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-25845641

RESUMO

CONTEXT: Eucommia ulmoides Oliver (Eucommiaceae) leaf exhibits beneficial lipid-lowering and anti-obesity effects. However, the mechanisms remain unknown. OBJECTIVE: The objective of this study is to investigate the lipid-lowering effects of chlorogenic acid (CGA)-enriched extract from this plant (CAEF) in human hepatoma HepG2 cells, focusing on cholesterol metabolism. MATERIALS AND METHODS: HepG2 cells were treated with CAEF (10, 20, 25, 40, 60, and 80 mg/L), CGA (0.3, 3, 30, 300, and 600 µmol/L), and simvastatin (0.1, 1, 10, 50, and 100 µmol/L) for 24 or 48 h. The cytotoxicity, Oil red O staining, total cholesterol, and triacylglycerol in supernatants were determined. The mRNA expression of genes involved in cholesterol metabolism was determined with RT-PCR. The protein expression of HMG-CoA reductase (HMGCR) was examined by immunocytochemistry and western-blot. RESULTS: The IC50 values were 59.2 mg/L for CAEF, 335.9 µmol/L for CGA, and 10.5 µmol/L for simvastatin. By treating cells with CAEF (25 mg/L), CGA (30 µmol/L), or simvastatin (10 µmol/L) for 48 h, the efflux of total cholesterol and triacylglycerol was increased (CAEF, 4.06- and 31.00-folds; CGA, 2.94- and 2.17-folds; and simvastatin, 3.94- and 24.67-folds), and the cellular lipid droplets were reduced in Oil red O staining. CAEF and CGA increased mRNA expression of ABCA1, CYP7A1, and AMPKα2, while CAEF and simvastatin decreased SREBP2. However, their effects on LXRα mRNA expression were variable. Importantly, all drugs significantly inhibited protein expression of HMGCR at mRNA and protein levels. DISCUSSION AND CONCLUSION: CAEF is a promising dietary supplement to prevent obesity and dyslipidemia and the effects appear to be due, at least in part, to regulating cholesterol metabolism through inhibition of HMGCR in HepG2 cells.


Assuntos
Ácido Clorogênico/química , Colesterol/metabolismo , Medicamentos de Ervas Chinesas/farmacologia , Eucommiaceae/química , Metabolismo dos Lipídeos/efeitos dos fármacos , Fígado/metabolismo , Relação Dose-Resposta a Droga , Medicamentos de Ervas Chinesas/isolamento & purificação , Expressão Gênica/efeitos dos fármacos , Células Hep G2 , Humanos , Metabolismo dos Lipídeos/genética , Fígado/efeitos dos fármacos , Folhas de Planta/química
4.
Virology ; 433(2): 395-400, 2012 Nov 25.
Artigo em Inglês | MEDLINE | ID: mdl-22995187

RESUMO

Human papillomaviruses (HPV) are small DNA tumor viruses. HPV infection requires entry of virions into epithelial host cells that support the viral life cycle. Here, we used an in vivo mouse model, in which HPV pseudoviruses (PVs) are scored for their ability to transduce reporter genes, to test the role of various cellular proteins in entry. We initially investigated the role of integrin α(6)ß(4) in mediating early steps of HPV infection. Deficiency of integrin α(6)ß(4) is modestly but significantly suppressed reporter-gene transduction by PVs in conditional integrin ß(4) knockout mice. We also investigated the role of syndecan 1, a heparin sulfate proteoglycan (HSPG) for its role in HPV infection. We did not see a significant reduction in reporter-gene transduction by PVs in syndecan-1 null mice. This indicates that this HSPG is not essential for early steps in HPV infection, but does not discount a need of other HSPGs in mediating HPV infection.


Assuntos
Integrina alfa6beta4/metabolismo , Infecções por Papillomavirus/etiologia , Sindecana-1/metabolismo , Animais , Modelos Animais de Doenças , Feminino , Genes Virais , Papillomavirus Humano 16/genética , Papillomavirus Humano 16/patogenicidade , Humanos , Integrina alfa6beta4/deficiência , Integrina alfa6beta4/genética , Camundongos , Camundongos Knockout , Infecções por Papillomavirus/imunologia , Infecções por Papillomavirus/metabolismo , Infecções por Papillomavirus/virologia , Receptores Virais/metabolismo , Sindecana-1/deficiência , Sindecana-1/genética , Transdução Genética
5.
Antiviral Res ; 93(2): 280-287, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22197636

RESUMO

The future incidence of cervical cancer is forecast to decline because of the remarkably effective prophylactic vaccines against human papillomaviruses. However, lack of access to these expensive vaccines in the developing countries where cervical cancer is most frequent, and the restricted genotypes these vaccines protect against, will limit their impact. Clearly, there is still a need for identifying other modalities for preventing HPV infections. Ready access to effective, inexpensive antivirals represents one potentially valuable approach to the prevention of genital HPV infections. We developed a well-validated high throughput screening (HTS) assay for identifying compounds that inhibit HPV infection and applied this assay to identify lead compounds that act by inhibiting an early step in infection. We screened over 40,000 small molecules that were available at the University of Wisconsin Small Molecule Screening Facility (UW-SMSF). The top 22 compounds were chosen for further analyses based upon the pharmacological property, scaffold diversity, strength of the inhibitory activity and lack of nonspecific cytotoxicity. Of these compounds, #13 and #14 had the most acceptable properties of low to submicromolar IC(50)'s and low cytotoxicity. Optimal antiviral activities were elicited by exposure of cells to the #13 and #14 during the initial 12 h following infection. Twenty-nine #13-like and 15 #14-like analogs were identified in silico and tested for their antiviral activities corresponded to the altered structures comparing to #13 and #14, informing on the pharmacophore structure of each compound. Studies indicate that both compounds inhibit infection post-entry.


Assuntos
Alphapapillomavirus/efeitos dos fármacos , Alphapapillomavirus/fisiologia , Antivirais/farmacologia , Ensaios de Seleção de Medicamentos Antitumorais , Infecções por Papillomavirus/virologia , Alphapapillomavirus/genética , Antivirais/química , Linhagem Celular , Feminino , Humanos , Infecções por Papillomavirus/tratamento farmacológico , Bibliotecas de Moléculas Pequenas
6.
Virology ; 407(2): 391-6, 2010 Nov 25.
Artigo em Inglês | MEDLINE | ID: mdl-20875908

RESUMO

Human papillomaviruses (HPV) are common sexually transmitted pathogens that predispose women to cervical and other anogenital cancers. HPV vaccines can prevent infection by some but not other sexually transmitted HPVs but are too costly for use in much of the world at greatest risk to HPV-associated cancers. Microbicides provide an inexpensive alternative to vaccines. In a high throughput screen, drugs that inhibit the cellular protein complex known as gamma secretase were identified as potential HPV microbicides. gamma Secretase inhibitors (GSIs) inhibited the infectivity of HPV pseudoviruses both in human keratinocytes and in mouse cells, with IC(50) values in the picomolar to the nanomolar range. Using a mouse model, we observed that a GSI could inhibit HPV infection to the same degree as its effectiveness in inhibiting gamma secretase activity in vivo. We conclude that gamma secretase activity is required for HPV infection and that GSIs are effective microbicides against anogenital HPVs.


Assuntos
Secretases da Proteína Precursora do Amiloide/antagonistas & inibidores , Carbamatos/farmacologia , Dipeptídeos/farmacologia , Doenças dos Genitais Femininos/tratamento farmacológico , Papillomavirus Humano 16/efeitos dos fármacos , Infecções por Papillomavirus/tratamento farmacológico , Animais , Anti-Infecciosos/administração & dosagem , Anti-Infecciosos/farmacologia , Carbamatos/administração & dosagem , Linhagem Celular , Células Cultivadas , Dipeptídeos/administração & dosagem , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Feminino , Doenças dos Genitais Femininos/virologia , Papillomavirus Humano 16/enzimologia , Papillomavirus Humano 16/patogenicidade , Humanos , Queratinócitos/virologia , Camundongos , Infecções por Papillomavirus/virologia , Resultado do Tratamento
7.
Zhonghua Wai Ke Za Zhi ; 47(3): 218-21, 2009 Feb 01.
Artigo em Chinês | MEDLINE | ID: mdl-19563079

RESUMO

OBJECTIVE: To explore the effect of rosiglitazone on the activity of signal transducer and activator of transcription 1 in rats with severe acute pancreatitis. METHODS: Fifty-four male Wistar rats were randomly allocated into three groups (n = 18). SO group: sham-operated animals served as control, operation was executed and sodium chloride but not sodium taurocholate was injected. SAP group: SAP was induced by the retrograde injection of 5% sodium taurocholate into the biliopancreatic duct. ROSI group: same as SAP group, but rosiglitazone (6 mg/kg) was administered intravenously 30 min before operation. Rats in each group were sacrificed at 3,6 and 12 h after operation. The levels of serum amylase and histologic scores of pancreatic tissue were measured. The expression of TNF-alpha mRNA in pancreatic tissue were determined by reverse transcription-polymerase chain reaction (RT-PCR). The expression of phosphorylated STAT1 in pancreatic tissue was assayed by immunohistochemistry. RESULTS: Compared to SO group, the levels of serum amylase and phosphorylated STAT1, TNF-alpha mRNA and histologic scores of pancreatic tissue were significantly elevated at the same time points after SAP (P < 0.01). The levels of these detection in ROSI group were lower than those of the SAP group at the same time points (P < 0.05), but higher than SO group (P < 0.05). CONCLUSIONS: STAT1 was activated in severe acute pancreatitis. Rosiglitazone has a protective effects in rats with severe acute pancreatitis. The mechanism of its protective effects maybe that it inhibits the activation of JAK/STAT pathway, which can down-regulate the expression of TNF-alpha mRNA and block the the inflammatory cascade partially.


Assuntos
Pâncreas/metabolismo , Pancreatite/metabolismo , Fator de Transcrição STAT1/metabolismo , Tiazolidinedionas/farmacologia , Doença Aguda , Animais , Modelos Animais de Doenças , Masculino , Pâncreas/patologia , Pancreatite/tratamento farmacológico , Pancreatite/patologia , Distribuição Aleatória , Ratos , Ratos Wistar , Rosiglitazona
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA